Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

California Coal Tar Litigation Stay Sought Pending FDA Petition Review

This article was originally published in The Tan Sheet

Executive Summary

California litigation over the use of coal tar in dandruff shampoos and other OTCs should be stayed pending FDA review of the ingredient's safety, drug distributor Bergen Brunswig tells a San Francisco judge.

You may also be interested in...



Coal tar

FDA response to citizen petition requesting coal tar-containing products be restricted to Rx-only sales expected by Jan. 22. Perry Gottesfeld, a plaintiff in California Proposition 65 litigation against product manufacturers, asked the agency in March to conduct a "formal review" of coal tar's use in shampoo, soap and ointments. Consolidated trial in separate Prop 65 lawsuits brought by the state and Gottesfeld was stayed until Jan. 29 following defense requests the trial be postponed pending FDA's review (1"The Tan Sheet" Sept. 4, p. 16)

Coal tar

FDA response to citizen petition requesting coal tar-containing products be restricted to Rx-only sales expected by Jan. 22. Perry Gottesfeld, a plaintiff in California Proposition 65 litigation against product manufacturers, asked the agency in March to conduct a "formal review" of coal tar's use in shampoo, soap and ointments. Consolidated trial in separate Prop 65 lawsuits brought by the state and Gottesfeld was stayed until Jan. 29 following defense requests the trial be postponed pending FDA's review (1"The Tan Sheet" Sept. 4, p. 16)

Coal tar

FDA response to citizen petition requesting coal tar-containing products be restricted to Rx-only sales expected by Jan. 22. Perry Gottesfeld, a plaintiff in California Proposition 65 litigation against product manufacturers, asked the agency in March to conduct a "formal review" of coal tar's use in shampoo, soap and ointments. Consolidated trial in separate Prop 65 lawsuits brought by the state and Gottesfeld was stayed until Jan. 29 following defense requests the trial be postponed pending FDA's review (1"The Tan Sheet" Sept. 4, p. 16)

Related Content

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel